O

Otsuka Pharmaceutical

Global pharma maker of Abilify

Director – GTN Strategy & Policy Analytics

Corporate Finance & FP&AConfirmed live in the last 24 hours
Full-timeRemote in USARemote

About the Job

Requirements

  • At least 8 years of experience in pharmaceutical finance, pricing, gross-to-net, or market access analytics.
  • Direct ownership of gross-to-net or revenue forecasting for U.S. products is preferred.
  • Deep understanding of U.S. channel economics and government and commercial program mechanics, including Medicaid, Medicare Part D and coverage gap, commercial rebates, 340B, chargebacks, and wholesaler agreements.
  • Hands-on experience with financial planning and revenue management systems such as Anaplan, Model N, or SAP, and comfort working with large, complex data sets.
  • Strong grasp of the U.S. pricing and policy landscape, including the Inflation Reduction Act, inflation penalties, MFP, MFN concepts, and state transparency, and their implications for list price, contracting, and gross-to-net.
  • Demonstrated ability to lead cross-functional decision-making with Finance, Policy, Market Access, Brand, and Global stakeholders in a matrix organization.
  • Advanced analytical and modeling skills, including scenario and sensitivity analysis, with a track record of translating complex analytics into clear recommendations for senior leaders.
  • A bachelor's degree in Finance, Economics, Mathematics, Pharmacy, or a related field is required.
  • An MBA, MS in Finance, or similar advanced degree is preferred.

Responsibilities

  • Develop and recommend end-to-end U.S. gross-to-net forecasts for all inline products, including RF/budget submissions, long-range planning, and monthly updates, using Anaplan and home-grown models as core tools.
  • Provide gross-to-net inputs and assumptions to Finance and Accounting for accrual management and external financial reporting, ensuring alignment with the close calendar and external audit requirements.
  • Lead the design, enhancement, and execution of gross-to-net models at channel and product level, covering Medicaid, Medicare, commercial rebates, wholesaler and distribution, returns, copay, 340B, cash discounts, and disputes, and own consolidated portfolio-level output.
  • Run scenario analyses and ranges around base-case forecasts to quantify risk and opportunity, including shocks from policy changes, competitive events, and access shifts.
  • Partner with the U.S. Policy team to quantify the financial impact of current and proposed policies, including the Inflation Reduction Act, price appreciation caps, MFN concepts, and MFP/IRA selections, and advise on forecast treatment as embedded or scenario-only.
  • Lead recurring cross-functional gross-to-net governance with Finance, Gross-to-Net Accounting, Market Access Strategy, and Brand to align on volume, access, and rebate assumptions and monitor monthly trends, including 340B volatility.
  • Use modeling to predict future impacts to ASP, Medicaid URA, and 340B Price, and make recommendations for annual price changes.
  • Develop and maintain payer- and access-based gross-to-net drivers, partnering with Market Access Strategy to refresh payer-level access and rebate assumptions and integrate them into forecasts.
  • Oversee implementation, maintenance, and continuous improvement of the Anaplan gross-to-net planning environment, including automated data interfaces from Model N and external partners, and manage external consultants who support the platform.
  • Establish robust monitoring and diagnostics for gross-to-net performance, including daily, weekly, and monthly KPI review, variance analysis versus prior forecasts, and deep dives such as 340B spikes with Government Pricing and Audit teams.
  • Provide U.S. gross-to-net and pricing perspectives in senior-level forums, including U.S. leadership, Global Finance, and Pricing Committee, clearly communicating uncertainty, ranges, and key value drivers as the portfolio scales.
  • Partner with Finance through close cycles to ensure accurate balance sheet accruals and reconciliation.

Desired Qualifications

  • Direct ownership of gross-to-net or revenue forecasting for U.S. products is preferred.

About the Company

Otsuka Pharmaceutical

Global pharma maker of Abilify

Otsuka Pharmaceutical develops and markets medicines and health products worldwide, including prescription drugs and nutraceutical beverages. Its product lineup ranges from pharmaceutical treatments such as Abilify (an antipsychotic) to consumer health drinks like Pocari Sweat, which helps replenish electrolytes. Abilify works as a psychiatric medication used to treat conditions such as schizophrenia and bipolar disorder, while Pocari Sweat is an ion-replacement beverage designed to restore minerals and fluids after activity or heat. The company differentiates itself through a long history dating back to its founding in 1921, a broad, globally scaled portfolio spanning drugs and health beverages, and a focus on health improvements across populations. Its stated goal is to create new products for better health worldwide.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Tokyo, Japan
Founded
1921

Recently Posted Jobs

Explore more opportunities at Otsuka Pharmaceutical

See more jobs